Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

    Funds basic research on the harmful acute and delayed effects of ultra-potent synthetic opioids like fentanyl, including combinations, to develop countermeasures.

    OverviewSimilar Grants
    OverviewSimilar Grants

    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

    Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.

    HHS-NIH11Due Dec 16, 2026$350,000

    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

    NIDA plans to fund research developing interventions to prevent and treat substance use disorders and overdoses, from preclinical studies to clinical trials.

    HHS-NIH11Due Feb 22, 2027$15,000,000

    Opioid Abatement (2026)

    Opioid Abatement (2026) supports North Carolina higher education researchers studying opioid prevention and remediation to develop practical, evidence-based guidance for state and local policy and practice.

    NC CollaboratoryDue Oct 31, 2026· 4d$300,000

    Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

    This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.

    HHS-NIH11Due Nov 3, 2026· 7d

    HEAL Initiative Translating Addiction Epidemiology Prevention Treatment and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

    This grant funds research to speed up the use of proven addiction prevention, treatment, and recovery methods for opioid and overdose crises, focusing on scalable, evidence-based solutions at multiple levels.

    HHS-NIH11Due Feb 9, 2029